CC BY-NC-ND 4.0 · Endosc Int Open 2019; 07(10): E1262-E1275
DOI: 10.1055/a-0958-2183
Review
Owner and Copyright © Georg Thieme Verlag KG 2019

The role of EUS in diagnosis and treatment of liver disorders

Sara Campos
1  Department of Gastroenterology, Hospital Garcia da Orta, Portugal
2  Department of Gastroenterology and Hepatology, Erasmus MC, The Netherlands
,
Jan-Werner Poley
2  Department of Gastroenterology and Hepatology, Erasmus MC, The Netherlands
,
Lydi van Driel
2  Department of Gastroenterology and Hepatology, Erasmus MC, The Netherlands
,
Marco J. Bruno
2  Department of Gastroenterology and Hepatology, Erasmus MC, The Netherlands
› Author Affiliations
Further Information

Publication History

submitted 04 October 2018

accepted after revision 07 January 2019

Publication Date:
01 October 2019 (online)

  

Abstract

Background and aim Transabdominal ultrasound (US), computed tomographic scanning (CT) and magnetic resonance imaging (MRI) are established diagnostic tools for liver diseases. Percutaneous transhepatic cholangiography is used to perform hepatic interventional procedures including biopsy, biliary drainage procedures, and radiofrequency ablation. Despite their widespread use, these techniques have limitations. Endoscopic ultrasound (EUS), a tool that has proven useful for evaluating the mediastinum, esophagus, stomach, pancreas, and biliary tract, has an expanding role in the field of hepatology complementing the traditional investigational modalities. This review aimed to assess the current scientific evidence regarding diagnostic and therapeutic applications of EUS for hepatic diseases.